Northeast Texas Dialysis in Atlanta, Texas - Dialysis Center

Northeast Texas Dialysis is a medicare approved dialysis facility center in Atlanta, Texas and it has 13 dialysis stations. It is located in Cass county at 413-b Us Hwy 59, Atlanta, TX, 75551. You can reach out to the office of Northeast Texas Dialysis at (903) 796-1084. This dialysis clinic is managed and/or owned by Davita. Northeast Texas Dialysis has the following ownership type - Profit. It was first certified by medicare in May, 1995. The medicare id for this facility is 452710 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameNortheast Texas Dialysis
Location413-b Us Hwy 59, Atlanta, Texas
No. of Dialysis Stations 13
Medicare ID452710
Managed ByDavita
Ownership TypeProfit
Late Shifts No

Contact Information


413-b Us Hwy 59, Atlanta, Texas, 75551
(903) 796-1084

News Archive

Revealing statistics about childhood diabetes reported

The incidence rate of type 1 diabetes among non-Hispanic white youth in the United States is one of the highest in the world, according to a major national study coordinated by researchers at Wake Forest University Baptist Medical Center.

Mothers commonly talk to children about genetic test even it they test positive for gene mutation

Mothers commonly talk to their children about genetic test results even if they test positive for a BRCA1 or BRCA2 gene mutation, which sharply increases a woman's risk of developing breast and ovarian cancer.

FDA approves Brilinta to reduce cardiovascular death and heart attack in ACS patients

The U.S. Food and Drug Administration today approved the blood-thinning drug Brilinta (ticagrelor) to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS).

Artificial Intelligence in healthcare predicted to grow tenfold in next five years

Artificial Intelligence (AI) is revolutionising multiple areas of information technology and has exciting potential for applications in biomedicine. It is predicted that the use of AI in healthcare will grow tenfold in the next five years.

Scientists discover new approach to treating incurable leukemia in children

Acute lymphoblastic leukemia (ALL) is a form of blood cancer that primarily affects children and young people.

Read more Medical News

› Verified 1 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Northeast Texas Dialysis from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1821367830
Organization NameNortheast Texas Dialysis
Doing Business AsTotal Renal Care Inc
Address413b Us 59 Atlanta, Texas, 75551
Phone Number(903) 796-3311

News Archive

Revealing statistics about childhood diabetes reported

The incidence rate of type 1 diabetes among non-Hispanic white youth in the United States is one of the highest in the world, according to a major national study coordinated by researchers at Wake Forest University Baptist Medical Center.

Mothers commonly talk to children about genetic test even it they test positive for gene mutation

Mothers commonly talk to their children about genetic test results even if they test positive for a BRCA1 or BRCA2 gene mutation, which sharply increases a woman's risk of developing breast and ovarian cancer.

FDA approves Brilinta to reduce cardiovascular death and heart attack in ACS patients

The U.S. Food and Drug Administration today approved the blood-thinning drug Brilinta (ticagrelor) to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS).

Artificial Intelligence in healthcare predicted to grow tenfold in next five years

Artificial Intelligence (AI) is revolutionising multiple areas of information technology and has exciting potential for applications in biomedicine. It is predicted that the use of AI in healthcare will grow tenfold in the next five years.

Scientists discover new approach to treating incurable leukemia in children

Acute lymphoblastic leukemia (ALL) is a form of blood cancer that primarily affects children and young people.

Read more Medical News

› Verified 1 days ago


Survey of Patient's Experiences

Nephrologists Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that nephrologists always communicated and cared for them.75%67%
Patients who reported that nephrologists usually communicated and cared for them.9%15%
Patients who reported that nephrologists sometimes or never communicated and cared for them.16%18%
Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).63%60%
Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).24%26%
Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).13%14%

News Archive

Revealing statistics about childhood diabetes reported

The incidence rate of type 1 diabetes among non-Hispanic white youth in the United States is one of the highest in the world, according to a major national study coordinated by researchers at Wake Forest University Baptist Medical Center.

Mothers commonly talk to children about genetic test even it they test positive for gene mutation

Mothers commonly talk to their children about genetic test results even if they test positive for a BRCA1 or BRCA2 gene mutation, which sharply increases a woman's risk of developing breast and ovarian cancer.

FDA approves Brilinta to reduce cardiovascular death and heart attack in ACS patients

The U.S. Food and Drug Administration today approved the blood-thinning drug Brilinta (ticagrelor) to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS).

Artificial Intelligence in healthcare predicted to grow tenfold in next five years

Artificial Intelligence (AI) is revolutionising multiple areas of information technology and has exciting potential for applications in biomedicine. It is predicted that the use of AI in healthcare will grow tenfold in the next five years.

Scientists discover new approach to treating incurable leukemia in children

Acute lymphoblastic leukemia (ALL) is a form of blood cancer that primarily affects children and young people.

Read more Medical News

› Verified 1 days ago

Dialysis Center Staff Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible.58%62%
Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible.16%20%
Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free.26%18%
Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).65%62%
Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).19%26%
Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).16%12%

News Archive

Revealing statistics about childhood diabetes reported

The incidence rate of type 1 diabetes among non-Hispanic white youth in the United States is one of the highest in the world, according to a major national study coordinated by researchers at Wake Forest University Baptist Medical Center.

Mothers commonly talk to children about genetic test even it they test positive for gene mutation

Mothers commonly talk to their children about genetic test results even if they test positive for a BRCA1 or BRCA2 gene mutation, which sharply increases a woman's risk of developing breast and ovarian cancer.

FDA approves Brilinta to reduce cardiovascular death and heart attack in ACS patients

The U.S. Food and Drug Administration today approved the blood-thinning drug Brilinta (ticagrelor) to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS).

Artificial Intelligence in healthcare predicted to grow tenfold in next five years

Artificial Intelligence (AI) is revolutionising multiple areas of information technology and has exciting potential for applications in biomedicine. It is predicted that the use of AI in healthcare will grow tenfold in the next five years.

Scientists discover new approach to treating incurable leukemia in children

Acute lymphoblastic leukemia (ALL) is a form of blood cancer that primarily affects children and young people.

Read more Medical News

› Verified 1 days ago

Overall Dialysis Center Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. 86%80%
Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them.14%20%
Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).76%68%
Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).9%20%
Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).15%12%

News Archive

Revealing statistics about childhood diabetes reported

The incidence rate of type 1 diabetes among non-Hispanic white youth in the United States is one of the highest in the world, according to a major national study coordinated by researchers at Wake Forest University Baptist Medical Center.

Mothers commonly talk to children about genetic test even it they test positive for gene mutation

Mothers commonly talk to their children about genetic test results even if they test positive for a BRCA1 or BRCA2 gene mutation, which sharply increases a woman's risk of developing breast and ovarian cancer.

FDA approves Brilinta to reduce cardiovascular death and heart attack in ACS patients

The U.S. Food and Drug Administration today approved the blood-thinning drug Brilinta (ticagrelor) to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS).

Artificial Intelligence in healthcare predicted to grow tenfold in next five years

Artificial Intelligence (AI) is revolutionising multiple areas of information technology and has exciting potential for applications in biomedicine. It is predicted that the use of AI in healthcare will grow tenfold in the next five years.

Scientists discover new approach to treating incurable leukemia in children

Acute lymphoblastic leukemia (ALL) is a form of blood cancer that primarily affects children and young people.

Read more Medical News

› Verified 1 days ago

Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data33
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL3

News Archive

Revealing statistics about childhood diabetes reported

The incidence rate of type 1 diabetes among non-Hispanic white youth in the United States is one of the highest in the world, according to a major national study coordinated by researchers at Wake Forest University Baptist Medical Center.

Mothers commonly talk to children about genetic test even it they test positive for gene mutation

Mothers commonly talk to their children about genetic test results even if they test positive for a BRCA1 or BRCA2 gene mutation, which sharply increases a woman's risk of developing breast and ovarian cancer.

FDA approves Brilinta to reduce cardiovascular death and heart attack in ACS patients

The U.S. Food and Drug Administration today approved the blood-thinning drug Brilinta (ticagrelor) to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS).

Artificial Intelligence in healthcare predicted to grow tenfold in next five years

Artificial Intelligence (AI) is revolutionising multiple areas of information technology and has exciting potential for applications in biomedicine. It is predicted that the use of AI in healthcare will grow tenfold in the next five years.

Scientists discover new approach to treating incurable leukemia in children

Acute lymphoblastic leukemia (ALL) is a form of blood cancer that primarily affects children and young people.

Read more Medical News

› Verified 1 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center57
    Adult patient months included in Kt/V greater than or equal to 1.2473
    Percentage of adult patients getting regular hemodialysis at the center97
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Revealing statistics about childhood diabetes reported

    The incidence rate of type 1 diabetes among non-Hispanic white youth in the United States is one of the highest in the world, according to a major national study coordinated by researchers at Wake Forest University Baptist Medical Center.

    Mothers commonly talk to children about genetic test even it they test positive for gene mutation

    Mothers commonly talk to their children about genetic test results even if they test positive for a BRCA1 or BRCA2 gene mutation, which sharply increases a woman's risk of developing breast and ovarian cancer.

    FDA approves Brilinta to reduce cardiovascular death and heart attack in ACS patients

    The U.S. Food and Drug Administration today approved the blood-thinning drug Brilinta (ticagrelor) to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS).

    Artificial Intelligence in healthcare predicted to grow tenfold in next five years

    Artificial Intelligence (AI) is revolutionising multiple areas of information technology and has exciting potential for applications in biomedicine. It is predicted that the use of AI in healthcare will grow tenfold in the next five years.

    Scientists discover new approach to treating incurable leukemia in children

    Acute lymphoblastic leukemia (ALL) is a form of blood cancer that primarily affects children and young people.

    Read more Medical News

    › Verified 1 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Northeast Texas Dialysis with elevated calcium levels.

Patients with hypercalcemia57
Hypercalcemia patient months473
Patients with Serumphosphor63
Patients with Serumphosphor less than 3.5 mg/dL9
Patients with Serumphosphor from 3.5 to 4.5 mg/dL26
Patients with Serumphosphor from 4.6 to 5.5 mg/dL37
Patients with Serumphosphor from 5.6 to 7 mg/dL19
Patients with Serumphosphor greater than 7 mg/dL9

News Archive

Revealing statistics about childhood diabetes reported

The incidence rate of type 1 diabetes among non-Hispanic white youth in the United States is one of the highest in the world, according to a major national study coordinated by researchers at Wake Forest University Baptist Medical Center.

Mothers commonly talk to children about genetic test even it they test positive for gene mutation

Mothers commonly talk to their children about genetic test results even if they test positive for a BRCA1 or BRCA2 gene mutation, which sharply increases a woman's risk of developing breast and ovarian cancer.

FDA approves Brilinta to reduce cardiovascular death and heart attack in ACS patients

The U.S. Food and Drug Administration today approved the blood-thinning drug Brilinta (ticagrelor) to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS).

Artificial Intelligence in healthcare predicted to grow tenfold in next five years

Artificial Intelligence (AI) is revolutionising multiple areas of information technology and has exciting potential for applications in biomedicine. It is predicted that the use of AI in healthcare will grow tenfold in the next five years.

Scientists discover new approach to treating incurable leukemia in children

Acute lymphoblastic leukemia (ALL) is a form of blood cancer that primarily affects children and young people.

Read more Medical News

› Verified 1 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 56
Patient months included in arterial venous fistula and catheter summaries 416
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment57
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer12

News Archive

Revealing statistics about childhood diabetes reported

The incidence rate of type 1 diabetes among non-Hispanic white youth in the United States is one of the highest in the world, according to a major national study coordinated by researchers at Wake Forest University Baptist Medical Center.

Mothers commonly talk to children about genetic test even it they test positive for gene mutation

Mothers commonly talk to their children about genetic test results even if they test positive for a BRCA1 or BRCA2 gene mutation, which sharply increases a woman's risk of developing breast and ovarian cancer.

FDA approves Brilinta to reduce cardiovascular death and heart attack in ACS patients

The U.S. Food and Drug Administration today approved the blood-thinning drug Brilinta (ticagrelor) to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS).

Artificial Intelligence in healthcare predicted to grow tenfold in next five years

Artificial Intelligence (AI) is revolutionising multiple areas of information technology and has exciting potential for applications in biomedicine. It is predicted that the use of AI in healthcare will grow tenfold in the next five years.

Scientists discover new approach to treating incurable leukemia in children

Acute lymphoblastic leukemia (ALL) is a form of blood cancer that primarily affects children and young people.

Read more Medical News

› Verified 1 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary46
Hospitalization Rate in facility62.7 (Better than Expected)
Hospitalization Rate: Upper Confidence Limit167.5
Hospitalization Rate: Lower Confidence Limit25.1

News Archive

Revealing statistics about childhood diabetes reported

The incidence rate of type 1 diabetes among non-Hispanic white youth in the United States is one of the highest in the world, according to a major national study coordinated by researchers at Wake Forest University Baptist Medical Center.

Mothers commonly talk to children about genetic test even it they test positive for gene mutation

Mothers commonly talk to their children about genetic test results even if they test positive for a BRCA1 or BRCA2 gene mutation, which sharply increases a woman's risk of developing breast and ovarian cancer.

FDA approves Brilinta to reduce cardiovascular death and heart attack in ACS patients

The U.S. Food and Drug Administration today approved the blood-thinning drug Brilinta (ticagrelor) to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS).

Artificial Intelligence in healthcare predicted to grow tenfold in next five years

Artificial Intelligence (AI) is revolutionising multiple areas of information technology and has exciting potential for applications in biomedicine. It is predicted that the use of AI in healthcare will grow tenfold in the next five years.

Scientists discover new approach to treating incurable leukemia in children

Acute lymphoblastic leukemia (ALL) is a form of blood cancer that primarily affects children and young people.

Read more Medical News

› Verified 1 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Northeast Texas Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility6 (As Expected)
Readmission Rate: Upper Confidence Limit28.3
Readmission Rate: Lower Confidence Limit.2

News Archive

Revealing statistics about childhood diabetes reported

The incidence rate of type 1 diabetes among non-Hispanic white youth in the United States is one of the highest in the world, according to a major national study coordinated by researchers at Wake Forest University Baptist Medical Center.

Mothers commonly talk to children about genetic test even it they test positive for gene mutation

Mothers commonly talk to their children about genetic test results even if they test positive for a BRCA1 or BRCA2 gene mutation, which sharply increases a woman's risk of developing breast and ovarian cancer.

FDA approves Brilinta to reduce cardiovascular death and heart attack in ACS patients

The U.S. Food and Drug Administration today approved the blood-thinning drug Brilinta (ticagrelor) to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS).

Artificial Intelligence in healthcare predicted to grow tenfold in next five years

Artificial Intelligence (AI) is revolutionising multiple areas of information technology and has exciting potential for applications in biomedicine. It is predicted that the use of AI in healthcare will grow tenfold in the next five years.

Scientists discover new approach to treating incurable leukemia in children

Acute lymphoblastic leukemia (ALL) is a form of blood cancer that primarily affects children and young people.

Read more Medical News

› Verified 1 days ago

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Northeast Texas Dialysis get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility1 (As Expected)
SIR: Upper Confidence Limit2.73
SIR: Lower Confidence Limit.26

News Archive

Revealing statistics about childhood diabetes reported

The incidence rate of type 1 diabetes among non-Hispanic white youth in the United States is one of the highest in the world, according to a major national study coordinated by researchers at Wake Forest University Baptist Medical Center.

Mothers commonly talk to children about genetic test even it they test positive for gene mutation

Mothers commonly talk to their children about genetic test results even if they test positive for a BRCA1 or BRCA2 gene mutation, which sharply increases a woman's risk of developing breast and ovarian cancer.

FDA approves Brilinta to reduce cardiovascular death and heart attack in ACS patients

The U.S. Food and Drug Administration today approved the blood-thinning drug Brilinta (ticagrelor) to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS).

Artificial Intelligence in healthcare predicted to grow tenfold in next five years

Artificial Intelligence (AI) is revolutionising multiple areas of information technology and has exciting potential for applications in biomedicine. It is predicted that the use of AI in healthcare will grow tenfold in the next five years.

Scientists discover new approach to treating incurable leukemia in children

Acute lymphoblastic leukemia (ALL) is a form of blood cancer that primarily affects children and young people.

Read more Medical News

› Verified 1 days ago

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Northeast Texas Dialysis's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 43
Transfusion Rate in facility30.7 (As Expected)
Transfusion Rate: Upper Confidence Limit99.5
Transfusion Rate: Lower Confidence Limit10.9

News Archive

Revealing statistics about childhood diabetes reported

The incidence rate of type 1 diabetes among non-Hispanic white youth in the United States is one of the highest in the world, according to a major national study coordinated by researchers at Wake Forest University Baptist Medical Center.

Mothers commonly talk to children about genetic test even it they test positive for gene mutation

Mothers commonly talk to their children about genetic test results even if they test positive for a BRCA1 or BRCA2 gene mutation, which sharply increases a woman's risk of developing breast and ovarian cancer.

FDA approves Brilinta to reduce cardiovascular death and heart attack in ACS patients

The U.S. Food and Drug Administration today approved the blood-thinning drug Brilinta (ticagrelor) to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS).

Artificial Intelligence in healthcare predicted to grow tenfold in next five years

Artificial Intelligence (AI) is revolutionising multiple areas of information technology and has exciting potential for applications in biomedicine. It is predicted that the use of AI in healthcare will grow tenfold in the next five years.

Scientists discover new approach to treating incurable leukemia in children

Acute lymphoblastic leukemia (ALL) is a form of blood cancer that primarily affects children and young people.

Read more Medical News

› Verified 1 days ago

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at Northeast Texas Dialysis lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary193
Mortality Rate in facility13.3 (As Expected)
Mortality Rate: Upper Confidence Limit20.5
Mortality Rate: Lower Confidence Limit8.1

News Archive

Revealing statistics about childhood diabetes reported

The incidence rate of type 1 diabetes among non-Hispanic white youth in the United States is one of the highest in the world, according to a major national study coordinated by researchers at Wake Forest University Baptist Medical Center.

Mothers commonly talk to children about genetic test even it they test positive for gene mutation

Mothers commonly talk to their children about genetic test results even if they test positive for a BRCA1 or BRCA2 gene mutation, which sharply increases a woman's risk of developing breast and ovarian cancer.

FDA approves Brilinta to reduce cardiovascular death and heart attack in ACS patients

The U.S. Food and Drug Administration today approved the blood-thinning drug Brilinta (ticagrelor) to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS).

Artificial Intelligence in healthcare predicted to grow tenfold in next five years

Artificial Intelligence (AI) is revolutionising multiple areas of information technology and has exciting potential for applications in biomedicine. It is predicted that the use of AI in healthcare will grow tenfold in the next five years.

Scientists discover new approach to treating incurable leukemia in children

Acute lymphoblastic leukemia (ALL) is a form of blood cancer that primarily affects children and young people.

Read more Medical News

› Verified 1 days ago


Dialysis Facility in Atlanta, TX

Northeast Texas Dialysis
Location: 413-b Us Hwy 59, Atlanta, Texas, 75551
Phone: (903) 796-1084

News Archive

Revealing statistics about childhood diabetes reported

The incidence rate of type 1 diabetes among non-Hispanic white youth in the United States is one of the highest in the world, according to a major national study coordinated by researchers at Wake Forest University Baptist Medical Center.

Mothers commonly talk to children about genetic test even it they test positive for gene mutation

Mothers commonly talk to their children about genetic test results even if they test positive for a BRCA1 or BRCA2 gene mutation, which sharply increases a woman's risk of developing breast and ovarian cancer.

FDA approves Brilinta to reduce cardiovascular death and heart attack in ACS patients

The U.S. Food and Drug Administration today approved the blood-thinning drug Brilinta (ticagrelor) to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS).

Artificial Intelligence in healthcare predicted to grow tenfold in next five years

Artificial Intelligence (AI) is revolutionising multiple areas of information technology and has exciting potential for applications in biomedicine. It is predicted that the use of AI in healthcare will grow tenfold in the next five years.

Scientists discover new approach to treating incurable leukemia in children

Acute lymphoblastic leukemia (ALL) is a form of blood cancer that primarily affects children and young people.

Read more Medical News

› Verified 1 days ago


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.